Alarge number of infectious diseases and increasing cases of chronic diseases has been the key factor in the proliferation of the bioanalytical services market. According to MarketWatch, the global bioanalytical testing services market, worth USD 3.5 billion in 2022, is projected to reach USD 6.1 billion in 2027 at a compounding annual growth rate of 12.1 per cent. Several pharmaceutical organizations are collaborating with research institutes to provide efficient, cost-effective bioanalytical services to meet the increase in demand. Healthcare providers are looking to set up labs on-premise and partner with bioanalytical service providers to improve the efficiency of treatments. Furthermore, access to patients' genomic information is also revolutionizing the bioanalytical industry by providing crucial insights while developing and testing drugs.
In this edition of Life Sciences Review Europe, we present the list of the Top 10 Bioanalytical Services Companies in Europe for the year 2022. GermanOncology GmbH is a prominent company that utilizes its extensive real-world database to assist physicians in devising effective treatment plans for patients through its analysis, consulting, project management, and IT development services. We also bring to you thought leadership articles and exclusive insights from expert CIOs and CXOs - Dave Henderson, CIO, Millennium Health; Stefano Ferrara, Director, Clinical Science, BeiGene, presenting their views and opinions on how organizations can incorporate changes in the bioanalytics industry. We hope the valuable insights from industry thought leaders and the bioanalytics agencies featured in this edition help you make informed decisions for your organization.
Let us know your thoughts!